UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study

International journal of molecular sciences, 2023-06, Vol.24 (11), p.9623

2023

Volltextzugriff (PDF)

PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis

International journal of molecular sciences, 2022-03, Vol.23 (7), p.3904

2022

Volltextzugriff (PDF)

Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice

PloS one, 2018-06, Vol.13 (6), p.e0196048-e0196048

2018

Volltextzugriff (PDF)

Induction of Scleroderma Fibrosis in Skin‐Humanized Mice by Administration of Anti−Platelet‐Derived Growth Factor Receptor Agonistic Autoantibodies

Arthritis & rheumatology (Hoboken, N.J.), 2016-09, Vol.68 (9), p.2263-2273

2016

Volltextzugriff (PDF)

Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine

International journal of molecular sciences, 2023-08, Vol.24 (16), p.12548

2023

Volltextzugriff (PDF)

Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis

The New England journal of medicine, 2006-06, Vol.354 (25), p.2667-2676

2006

Volltextzugriff (PDF)

Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

Mechanisms of ageing and development, 2021-01, Vol.193, p.111413-111413, Article 111413

2021

Volltextzugriff (PDF)

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches

Biomedicines, 2022-01, Vol.10 (1), p.163

2022

Volltextzugriff (PDF)

Agonistic antibodies in systemic sclerosis

Immunology letters, 2018-03, Vol.195, p.83-87

2018

Volltextzugriff (PDF)

Association between TNF-α, cortisol levels, and exposure to PM10 and PM2.5: a pilot study

Environmental sciences Europe, 2024-08, Vol.36 (1), p.141-16, Article 141

2024

Volltextzugriff (PDF)

Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis

Science signaling, 2014-09, Vol.7 (341), p.ra84

2014

Volltextzugriff (PDF)

Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients

Frontiers in immunology, 2022-01, Vol.12, p.805705-805705

2022

Volltextzugriff (PDF)

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD

Blood, 2013-12, Vol.122 (25), p.4111-4118

2013

Volltextzugriff (PDF)

Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis

PloS one, 2010-11, Vol.5 (11), p.e14003

2010

Volltextzugriff (PDF)

Putative functional pathogenic autoantibodies in systemic sclerosis

European journal of rheumatology, 2020-10, Vol.7 (Suppl 3), p.S181-186

2020

Volltextzugriff (PDF)

A Reactive Oxygen Species–Mediated Loop Maintains Increased Expression of NADPH Oxidases 2 and 4 in Skin Fibroblasts From Patients With Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2015-06, Vol.67 (6), p.1611-1622

2015

Volltextzugriff (PDF)

Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality

Mechanisms of ageing and development, 2022-03, Vol.202, p.111636-111636, Article 111636

2022

Volltextzugriff (PDF)

Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2

Arthritis research & therapy, 2015-03, Vol.17 (1), p.68-68, Article 68

2015

Volltextzugriff (PDF)

Oxidative stress and the pathogenesis of scleroderma: the Murrell’s hypothesis revisited

Seminars in immunopathology, 2008-07, Vol.30 (3), p.329-337

2008

Volltextzugriff (PDF)

NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis

Free radical biology & medicine, 2018-09, Vol.125, p.90-97

2018

Volltextzugriff (PDF)

Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement

Scientific reports, 2017-11, Vol.7 (1), p.14874-11, Article 14874

2017

Volltextzugriff (PDF)

Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study

Arthritis research & therapy, 2014-07, Vol.16 (4), p.R144-R144, Article R144

2014

Volltextzugriff (PDF)

Metabolomic profile of systemic sclerosis patients

Scientific reports, 2018-05, Vol.8 (1), p.7626-11, Article 7626

2018

Volltextzugriff (PDF)

Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis

Rheumatology (Oxford, England), 2021-01, Vol.60 (1), p.92-102

2021

Volltextzugriff (PDF)

Adeno‐Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2024-04, Vol.76 (4), p.620-630

2024

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(82)

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(49)
Humans
(41)
Female
(19)
Male
(17)
Middle Aged
(17)
Scleroderma
(15)
Systemic Sclerosis
(15)
Fibrosis
(14)
Adult
(13)
Rheumatology
(13)
Aged
(12)
Biochemistry & Molecular Biology
(12)
Animals
(11)
Scleroderma, Systemic - Immunology
(11)
Fibroblasts - Metabolism
(9)
Reactive Oxygen Species - Metabolism
(9)
Receptors, Platelet-Derived Growth Factor - Immunology
(9)
Cells, Cultured
(8)
Gastroenterology & Hepatology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study

PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis

Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice

Induction of Scleroderma Fibrosis in Skin‐Humanized Mice by Administration of Anti−Platelet‐Derived Growth Factor Receptor Agonistic Autoantibodies

Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine

Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis

Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches

Agonistic antibodies in systemic sclerosis

Association between TNF-α, cortisol levels, and exposure to PM10 and PM2.5: a pilot study

Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis

Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD

Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis

Putative functional pathogenic autoantibodies in systemic sclerosis

A Reactive Oxygen Species–Mediated Loop Maintains Increased Expression of NADPH Oxidases 2 and 4 in Skin Fibroblasts From Patients With Systemic Sclerosis

Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality

Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2

Oxidative stress and the pathogenesis of scleroderma: the Murrell’s hypothesis revisited

NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis

Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement

Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study

Metabolomic profile of systemic sclerosis patients

Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis

Adeno‐Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis

Suchergebnisse filtern